Los Angeles Capital Management & Equity Research Inc. Cuts Stake in HCA Healthcare Inc (HCA)
Los Angeles Capital Management & Equity Research Inc. lowered its position in shares of HCA Healthcare Inc (NYSE:HCA) by 16.9% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 121,919 shares of the company’s stock after selling 24,810 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in HCA Healthcare were worth $16,961,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently made changes to their positions in HCA. Smithfield Trust Co. boosted its position in HCA Healthcare by 541.9% during the 2nd quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock valued at $102,000 after buying an additional 840 shares during the period. Signet Financial Management LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at $137,000. Adviser Investments LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at $159,000. Bridgeworth LLC purchased a new stake in HCA Healthcare during the 2nd quarter valued at $173,000. Finally, Hyman Charles D purchased a new stake in HCA Healthcare during the 2nd quarter valued at $205,000. 70.84% of the stock is owned by institutional investors and hedge funds.
NYSE:HCA opened at $143.95 on Friday. The stock has a market cap of $48.75 billion, a price-to-earnings ratio of 15.92, a PEG ratio of 1.24 and a beta of 0.48. HCA Healthcare Inc has a fifty-two week low of $74.26 and a fifty-two week high of $144.18.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Shareholders of record on Monday, December 3rd will be paid a dividend of $0.35 per share. The ex-dividend date of this dividend is Friday, November 30th. This represents a $1.40 dividend on an annualized basis and a yield of 0.97%. HCA Healthcare’s dividend payout ratio is currently 21.24%.
Several equities research analysts have weighed in on HCA shares. Jefferies Financial Group reissued a “buy” rating and set a $135.00 price target on shares of HCA Healthcare in a research report on Thursday, July 26th. SunTrust Banks increased their price target on shares of HCA Healthcare to $145.00 and gave the company a “buy” rating in a research report on Thursday, July 26th. Cantor Fitzgerald reissued a “buy” rating and set a $115.00 price target on shares of HCA Healthcare in a research report on Friday, July 20th. ValuEngine raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Wednesday, July 18th. Finally, Zacks Investment Research upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating and set a $119.00 price objective for the company in a report on Monday, July 16th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $141.53.
In other HCA Healthcare news, SVP Jane D. Englebright sold 6,543 shares of the firm’s stock in a transaction dated Wednesday, August 15th. The shares were sold at an average price of $129.86, for a total transaction of $849,673.98. Following the completion of the sale, the senior vice president now directly owns 7,443 shares in the company, valued at approximately $966,547.98. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Deborah M. Reiner sold 723 shares of the firm’s stock in a transaction dated Monday, November 5th. The shares were sold at an average price of $135.06, for a total transaction of $97,648.38. Following the sale, the senior vice president now directly owns 6,184 shares in the company, valued at approximately $835,211.04. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,486 shares of company stock valued at $3,079,086. 2.80% of the stock is owned by company insiders.
TRADEMARK VIOLATION WARNING: “Los Angeles Capital Management & Equity Research Inc. Cuts Stake in HCA Healthcare Inc (HCA)” was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2018/11/10/los-angeles-capital-management-equity-research-inc-cuts-stake-in-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Further Reading: Technical Analysis of Stocks, How Can It Help
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.